Reporter July 29 2022

Pregnant woman holding pill pack

Targeted cancer drug during pregnancy

The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians.

H. pylori and lung cancer

Specific biomarkers for H. pylori — a bacterium that infects the stomach — were associated with increased risk of lung cancer, Vanderbilt researchers have discovered.

Video vital for telehealth visits

Vanderbilt study of 18,130 telehealth visits at the beginning of the COVID-19 pandemic defines risk factors associated with telehealth access and suggests how health systems can improve access.

Specialty pharmacists help reduce MS relapse risk

Just one-third of patients with relapsing multiple sclerosis remain on disease-modifying therapy, and specialty pharmacists are in a unique position to help coordinate therapy discontinuation or change and reduce the risk of relapse.

First-year School of Medicine student Aamina Dandy puts on her white coat at last week’s ceremony as Jeff Balser, MD, PhD, and Amy Fleming, MD, look on.

White Coat Ceremony marks start of medical school journey

Vanderbilt University School of Medicine welcomed 96 first-year students on Friday, July 22, during its annual White Coat Ceremony.

C. difficile may contribute to colorectal cancer: study

A Vanderbilt study found that the bacterium Clostridioides difficile (C. difficile) may be a previously unrecognized contributor to colorectal cancer.

1 2